Ratcliffe Peter John 4

What Happened

• Peter John Ratcliffe, a director of Immunocore Holdings plc (IMCR), was granted a derivative award covering 27,492 shares on 2026-05-27. The award shows a $0 purchase price (no cash paid) and is reported as an acquisition (award/option), not a sale or exercise.

Key Details

• Transaction date: 2026-05-27; Filing date: 2026-05-28 (timely filing).
• Transaction type: Award/derivative (option award covering 27,492 shares); reported price $0.00.
• Shares owned after the transaction: Not disclosed in this filing.
• Footnote: The award vests at the earlier of (i) May 27, 2027 or (ii) the day before the issuer’s next annual general meeting, subject to Ratcliffe’s continuous service through the vesting date.
• No indication this was an immediate exercise or sale; it’s a future-vesting compensation award.

Context

• This filing reports a grant of a derivative compensation award (likely stock options) that will convert to equity only if and when it vests and any exercise conditions are met. Such awards are typically part of executive/director compensation or retention and do not represent an immediate buy/sell decision by the insider.